Fda Panel Backs Lower-cost Version Of J&j's Top-selling Drug

Federal health advisers on Tuesday endorsed a lower-cost version of Johnson & Johnson's blockbuster Remicade, a pricey biotech medicine used to treat a number of inflammatory diseases.

Topics:  johnson   remicade   johnson   lower-cost version   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News